{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:12Z","timestamp":1787995032164,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10067-026-08272-y","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:51:59Z","timestamp":1784033519000},"page":"5641-5651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum growth differentiation factor 15 as a candidate biomarker associated with interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome: a clinical cross-sectional study"],"prefix":"10.1007","volume":"45","author":[{"given":"Meilu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashuang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongtai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8288-1085","authenticated-orcid":false,"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"1","key":"8272_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ et al (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9\u201316","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8272_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (2015) Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1983\u20131989","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8272_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","volume":"53","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Solans R, Camps MT, Casanovas A, Sope\u00f1a B, D\u00edaz-L\u00f3pez B, Rasc\u00f3n FJ, Qanneta R, Fraile G et al (2014) Systemic involvement in primary Sjogren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology (Oxford) 53(2):321\u2013331","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8272_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105237","volume":"88","author":"A Manfredi","year":"2021","unstructured":"Manfredi A, Vacchi C, DellaCasa G, Cerri S, Cassone G, Di Cecco G, Luppi F, Salvarani C, Sebastiani M (2021) Fibrosing interstitial lung disease in primary Sjogren syndrome. Jt Bone Spine 88(6):105237","journal-title":"Jt Bone Spine"},{"issue":"11","key":"8272_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003569","volume":"3","author":"C Nannini","year":"1976","unstructured":"Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL (1976) Primary Sjogren\u2019s syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open 3(11):e003569","journal-title":"BMJ Open"},{"key":"8272_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss BJ, Ryter SW, Rosas IO (2022) Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol 17:515\u2013546","journal-title":"Annu Rev Pathol"},{"key":"8272_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103428","author":"G La Rocca","year":"2023","unstructured":"La Rocca G, Ferro F, Sambataro G (2023) Primary-Sj\u00f6gren\u2019s-syndrome-related interstitial lung disease: a clinical review discussing current controversies. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12103428","journal-title":"J Clin Med"},{"issue":"6","key":"8272_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","volume":"171","author":"I Ito","year":"2005","unstructured":"Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, Kim DS, Handa T, Izumi T, Mishima M (2005) Pulmonary manifestations of primary Sjogren\u2019s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171(6):632\u2013638","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"8272_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073774","volume":"8","author":"Y Enomoto","year":"2013","unstructured":"Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, Sakai F, Baba T, Nagaoka S, Ogura T (2013) Prognostic factors in interstitial lung disease associated with primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS ONE 8(9):e73774","journal-title":"PLoS ONE"},{"issue":"Suppl 126","key":"8272_CR10","first-page":"291","volume":"38","author":"F Luppi","year":"2020","unstructured":"Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A (2020) Interstitial lung disease in Sj\u00f6gren\u2019s syndrome: a clinical review. Clin Exp Rheumatol 38(Suppl 126):291\u2013300","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"8272_CR11","first-page":"2","volume":"32","author":"A Fischer","year":"2015","unstructured":"Fischer A, Chartrand S (2015) Assessment and management of connective tissue disease-associated interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 32(1):2\u201321","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"8272_CR12","doi-asserted-by":"publisher","first-page":"9.23.21","DOI":"10.1002\/cpph.19","volume":"76","author":"JK Aronson","year":"2017","unstructured":"Aronson JK, Ferner RE (2017) Biomarkers-a general review. Curr Protoc Pharmacol 76:9.23.21-29.23.17","journal-title":"Curr Protoc Pharmacol"},{"issue":"140","key":"8272_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Eur Respir Rev 25(140):110\u2013123","journal-title":"Eur Respir Rev"},{"issue":"1","key":"8272_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","volume":"63","author":"KC Wollert","year":"2017","unstructured":"Wollert KC, Kempf T, Wallentin L (2017) Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem 63(1):140\u2013151","journal-title":"Clin Chem"},{"issue":"3","key":"8272_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.31083\/j.rcm2403081","volume":"24","author":"A Schwarz","year":"2023","unstructured":"Schwarz A, Kinscherf R, Bonaterra GA (2023) Role of the stress- and inflammation-induced cytokine GDF-15 in cardiovascular diseases: from basic research to clinical relevance. Rev Cardiovasc Med 24(3):81","journal-title":"Rev Cardiovasc Med"},{"key":"8272_CR16","volume":"9","author":"AM di Candia","year":"2021","unstructured":"di Candia AM, de Avila DX, Moreira GR, Villacorta H, Maisel AS (2021) Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases. Am Heart J Plus: Cardiol Res Pract 9:100046","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"key":"8272_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen J, Melero I, Fridman WH (2020) Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol 11:951","journal-title":"Front Immunol"},{"key":"8272_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891448","volume":"13","author":"M Cao","year":"2022","unstructured":"Cao M, Gu L, Guo L, Liu M, Wang T, Zhang J, Zhang H, Zhang Y, Shi Y, Zhao Y et al (2022) Elevated expression of growth differentiation factor-15 is associated with acute exacerbation of idiopathic pulmonary fibrosis. Front Immunol 13:891448","journal-title":"Front Immunol"},{"issue":"2","key":"8272_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/art.38241","volume":"66","author":"S Lambrecht","year":"2014","unstructured":"Lambrecht S, Smith V, De Wilde K, Coudenys J, Decuman S, Deforce D, De Keyser F, Elewaut D (2014) Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Arthritis Rheumatol (Hoboken, NJ) 66(2):418\u2013427","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"5","key":"8272_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s10165-011-0568-7","volume":"22","author":"K Yanaba","year":"2012","unstructured":"Yanaba K, Asano Y, Tada Y, Sugaya M, Kadono T, Sato S (2012) Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity. Mod Rheumatol 22(5):668\u2013675","journal-title":"Mod Rheumatol"},{"issue":"9","key":"8272_CR21","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00296-018-4109-y","volume":"38","author":"J Lee","year":"2018","unstructured":"Lee J, Koh JH (2018) Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren\u2019s syndrome in a Korean cohort. Rheumatol Int 38(9):1651\u20131660","journal-title":"Rheumatol Int"},{"issue":"7624","key":"8272_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (Clinical research ed) 335(7624):806\u2013808","journal-title":"BMJ (Clinical research ed)"},{"issue":"6","key":"8272_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C (2010) EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 69(6):1103\u20131109","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8272_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, M\u00fcller NL, Remy J (2008) Fleischner society: glossary of terms for thoracic imaging. Radiology 246(3):697\u2013722","journal-title":"Radiology"},{"issue":"10","key":"8272_CR25","first-page":"1520","volume":"18","author":"JH Warrick","year":"1991","unstructured":"Warrick JH, Bhalla M, Schabel SI, Silver RM (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18(10):1520\u20131528","journal-title":"J Rheumatol"},{"issue":"11","key":"8272_CR26","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177(11):1248\u20131254","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"8272_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1165\/rcmb.2023-0429OC","volume":"70","author":"FA Shah","year":"2024","unstructured":"Shah FA, Bahudhanapati H, Jiang M, Tabary M, van der Geest R, Tolman NJ, Kochin M, Xiong Z, Al-Yousif N (2024) Lung epithelium releases growth differentiation factor 15 in response to pathogen-mediated injury. Am J Respir Cell Mol Biol 70(5):379\u2013391","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"8272_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1165\/rcmb.2018-0379TR","volume":"60","author":"FM Verhamme","year":"2019","unstructured":"Verhamme FM, Freeman CM (2019) GDF-15 in pulmonary and critical care medicine. Am J Respir Cell Mol Biol 60(6):621\u2013628","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"8272_CR29","doi-asserted-by":"publisher","first-page":"20007","DOI":"10.1038\/s41598-025-03698-x","volume":"15","author":"J Fu","year":"2025","unstructured":"Fu J, Peng W, Wu Q, Zhang Y, Wang W, Wu S (2025) Serum growth differentiation factor 15 associates with extra-glandular manifestations and disease activity of primary Sj\u00f6gren\u2019s syndrome. Sci Rep 15(1):20007","journal-title":"Sci Rep"},{"key":"8272_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113180","author":"B De Paepe","year":"2022","unstructured":"De Paepe B (2022) The cytokine growth differentiation factor-15 and skeletal muscle health: portrait of an emerging widely applicable disease biomarker. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113180","journal-title":"Int J Mol Sci"},{"key":"8272_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/490842","author":"R Adela","year":"2015","unstructured":"Adela R, Banerjee SK (2015) GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J Diabetes Res. https:\/\/doi.org\/10.1155\/2015\/490842","journal-title":"J Diabetes Res"},{"issue":"1","key":"8272_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/s41598-023-49459-6","volume":"14","author":"A Alarcon-Dionet","year":"2024","unstructured":"Alarcon-Dionet A, Ruiz A, Chavez-Galan L, Buendia-Roldan I, Selman M (2024) GDF15 as a potential biomarker to distinguish fibrotic from non-fibrotic hypersensitivity pneumonitis. Sci Rep 14(1):859","journal-title":"Sci Rep"},{"key":"8272_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153058","author":"A Radwanska","year":"2022","unstructured":"Radwanska A, Cottage CT, Piras A, Overed-Sayer C, Sihlbom C, Budida R, Wrench C, Connor J, Monkley S, Hazon P et al (2022) Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.153058","journal-title":"JCI Insight"},{"issue":"1","key":"8272_CR34","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.1038\/s41598-023-35608-4","volume":"13","author":"KA Lee","year":"2023","unstructured":"Lee KA, Nam BD, Hwang JH, Kim HS (2023) Clinical course and risk factors for development and progression of interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome. Sci Rep 13(1):9189","journal-title":"Sci Rep"},{"key":"8272_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164963","author":"G La Rocca","year":"2024","unstructured":"La Rocca G, Ferro F, Sambataro G (2024) Interstitial lung disease phenotypes and predictive risk factors in primary Sj\u00f6gren\u2019s syndrome. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13164963","journal-title":"J Clin Med"},{"issue":"1","key":"8272_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s40001-022-00828-3","volume":"27","author":"L Weng","year":"2022","unstructured":"Weng L, Chen Y, Liang T, Lin Y, Liu D, Yu C, Hu Y, Lui W, Liu Y, Chen X et al (2022) Biomarkers of interstitial lung disease associated with primary Sj\u00f6gren\u2019s syndrome. Eur J Med Res 27(1):199","journal-title":"Eur J Med Res"},{"key":"8272_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad265","author":"DS Evans","year":"2024","unstructured":"Evans DS, Young D, Tanaka T, Basisty N, Bandinelli S, Ferrucci L, Campisi J, Schilling B (2024) Proteomic analysis of the senescence-associated secretory phenotype: GDF-15, IGFBP-2, and cystatin-C are associated with multiple aging traits. J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glad265","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"8272_CR38","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1038\/s41598-022-09283-w","volume":"12","author":"YJ Kim","year":"2022","unstructured":"Kim YJ, Choe J, Moon SJ, Song JW (2022) Blood KL-6 predicts prognosis in primary Sj\u00f6gren\u2019s syndrome-associated interstitial lung disease. Sci Rep 12(1):5343","journal-title":"Sci Rep"},{"issue":"3","key":"8272_CR39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/23971983241307692","volume":"10","author":"A Velauthapillai","year":"2025","unstructured":"Velauthapillai A, de Vries-Bouwstra JK, Henes J, Czirjak L, Dagna L, Riemekastan G, Allanore Y, Foti R, Alegre-Sancho JJ, Maurer B et al (2025) Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: a EUSTAR database analysis. J Scleroderma Relat Disord 10(3):368\u2013376","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08272-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:35:28Z","timestamp":1787992528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08272-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8272"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08272-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study protocol was reviewed and approved by the Hebei General Hospital Medical Ethics Committee (Approval Number: IRB2016070). Written informed consent was obtained from all participants prior to their inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}